China Medical Technologies, Inc. (CMED) Tops Q2 EPS by 4c, Offers Q3 and FY12 Guidance
Tweet
Share
E-mailGet Alerts CMED Hot Sheet
Join SI Premium – FREE
China Medical Technologies, Inc. (NASDAQ: CMED) reported Q2 EPS of $0.53, $0.04 better than the analyst estimate of $0.49. Revenue for the quarter came in at $37.4 million versus the consensus estimate of $37.75 million.
China Medical Technologies, Inc. sees FY2012 EPS of $1.94-$1.98, versus the consensus of $1.81. China Medical Technologies, Inc. sees FY2012 revenue of $152.1-$153.7 million, versus the consensus of $154.35 million.
China Medical Technologies, Inc. sees Q3 2012 EPS of $0.50-$0.52. China Medical Technologies, Inc. sees Q3 2012 revenue of $38.4-$39.2 million.
China Medical Technologies, Inc. sees FY2012 EPS of $1.94-$1.98, versus the consensus of $1.81. China Medical Technologies, Inc. sees FY2012 revenue of $152.1-$153.7 million, versus the consensus of $154.35 million.
China Medical Technologies, Inc. sees Q3 2012 EPS of $0.50-$0.52. China Medical Technologies, Inc. sees Q3 2012 revenue of $38.4-$39.2 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
